Biomarkers early ovarian cancer early detection of cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cell Line, Tumor Tumor Cells, Cultured Neoplastic Stem Cells Breast Ovary Epithelial Cells Prostate Neoplastic Cells, Circulating

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases56

Ovarian Neoplasms Uterine Cervical Neoplasms Breast Neoplasms Neoplasms, Glandular and Epithelial Prostatic Neoplasms Cystadenocarcinoma, Serous Neoplasms Lung Neoplasms Neoplasm Invasiveness Carcinoma Neoplasm Metastasis Colonic Neoplasms Stomach Neoplasms Genetic Predisposition to Disease Disease Progression Pancreatic Neoplasms Colorectal Neoplasms Neoplasm Recurrence, Local Carcinoma, Squamous Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Mucinous Endometrial Neoplasms Carcinoma, Endometrioid Urinary Bladder Neoplasms Peritoneal Neoplasms Adenocarcinoma Carcinoma, Non-Small-Cell Lung Precancerous Conditions Cell Transformation, Neoplastic Ascites Mouth Neoplasms Esophageal Neoplasms Rectal Neoplasms Liver Neoplasms Genital Neoplasms, Female Neovascularization, Pathologic Cystadenocarcinoma Skin Neoplasms Head and Neck Neoplasms Neoplastic Syndromes, Hereditary Disease Models, Animal Fallopian Tube Neoplasms Neoplasms, Second Primary Melanoma Bone Neoplasms Gastrointestinal Neoplasms Neoplasms, Cystic, Mucinous, and Serous Neoplastic Cells, Circulating Neoplasms, Radiation-Induced Neoplasms, Multiple Primary Neoplasms, Hormone-Dependent Carcinoma, Small Cell Carcinoma in Situ Hereditary Breast and Ovarian Cancer Syndrome Adenoma Pharyngeal Neoplasms

Chemicals and Drugs51

Tumor Markers, Biological Biological Markers CA-125 Antigen Antineoplastic Agents Neoplasm Proteins Cisplatin Paclitaxel RNA, Messenger Cancer Vaccines DNA, Neoplasm BRCA2 Protein BRCA1 Protein Antigens, Neoplasm Prostate-Specific Antigen Epididymal Secretory Proteins Antineoplastic Agents, Phytogenic Receptor, erbB-2 RNA, Small Interfering Receptors, Estrogen Tumor Suppressor Protein p53 MicroRNAs Antibodies, Monoclonal Carboplatin DNA Primers Receptors, Progesterone Receptor, Epidermal Growth Factor Tumor Suppressor Proteins RNA, Neoplasm Tamoxifen Fluorouracil Antigens, Tumor-Associated, Carbohydrate Anticarcinogenic Agents DNA-Binding Proteins Proto-Oncogene Proteins Antineoplastic Agents, Hormonal Taxoids Transcription Factors Genetic Markers Nuclear Proteins Biomarkers, Pharmacological Carcinoembryonic Antigen Deoxycytidine Platinum Antibodies, Monoclonal, Humanized Proto-Oncogene Proteins c-akt Carcinogens Organoplatinum Compounds Mucin-1 Antibiotics, Antineoplastic Antimetabolites, Antineoplastic Radiopharmaceuticals

Analytical, Diagnostic and Therapeutic Techniques and Equipment80

Early Detection of Cancer Mammography Mass Screening Vaginal Smears Early Diagnosis Sensitivity and Specificity Prognosis Neoplasm Staging Reproducibility of Results Gene Expression Profiling Reverse Transcriptase Polymerase Chain Reaction Polymerase Chain Reaction Survival Analysis Risk Factors Prospective Studies Survival Rate Retrospective Studies Antineoplastic Combined Chemotherapy Protocols Predictive Value of Tests Follow-Up Studies Xenograft Model Antitumor Assays Risk Assessment Risk Oligonucleotide Array Sequence Analysis Blotting, Western Disease-Free Survival ROC Curve Immunohistochemistry Registries Neoplasm Transplantation Enzyme-Linked Immunosorbent Assay Odds Ratio Case-Control Studies Genetic Testing Combined Modality Therapy Treatment Outcome Multivariate Analysis Limit of Detection Kaplan-Meier Estimate Incidence Questionnaires Transplantation, Heterologous Tissue Array Analysis Immunoenzyme Techniques Clinical Trials as Topic Cohort Studies Logistic Models Neoplasm Grading Chemotherapy, Adjuvant Tumor Burden Drug Screening Assays, Antitumor Molecular Targeted Therapy Biopsy Protein Array Analysis Models, Biological DNA Mutational Analysis Immunoassay Flow Cytometry SEER Program Transfection Real-Time Polymerase Chain Reaction Disease Models, Animal Confidence Intervals Drug Administration Schedule False Positive Reactions Cluster Analysis Breast Self-Examination Gene Knockdown Techniques Pilot Projects Positron-Emission Tomography Tomography, X-Ray Computed Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization Diagnostic Imaging Mass Spectrometry Feasibility Studies Prevalence Radiotherapy Colonoscopy Magnetic Resonance Imaging In Situ Hybridization, Fluorescence

Psychiatry and Psychology2

Smoking Breast Self-Examination

Phenomena and Processes46

Sensitivity and Specificity Gene Expression Regulation, Neoplastic Genes, BRCA1 Drug Resistance, Neoplasm Genetic Predisposition to Disease Mutation Genes, BRCA2 Risk DNA Methylation Time Factors Cell Proliferation Genotype Germ-Line Mutation Odds Ratio Apoptosis Cell Survival Base Sequence Dose-Response Relationship, Drug Down-Regulation Cell Movement Algorithms Up-Regulation Promoter Regions, Genetic Genes, Tumor Suppressor Polymorphism, Genetic Signal Transduction Cell Division Cell Growth Processes Cell Cycle Genes, Neoplasm Gene Expression Gene Silencing Transfection RNA Interference Phenotype Diet Genetic Markers Epigenesis, Genetic Alleles Genes, p53 Heterozygote Postmenopause Drug Synergism Gene Amplification Phosphorylation CpG Islands

Disciplines and Occupations4

Proteomics Immunohistochemistry Medical Oncology Genetic Counseling

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science9

Survival Rate Registries Incidence Questionnaires Molecular Sequence Data Base Sequence Algorithms SEER Program Prevalence

Named Groups3

Medically Uninsured Survivors European Continental Ancestry Group

Health Care37

Mass Screening Sensitivity and Specificity Reproducibility of Results Survival Analysis Risk Factors Prospective Studies Survival Rate Retrospective Studies Predictive Value of Tests Follow-Up Studies Risk Assessment Risk Disease-Free Survival ROC Curve Age Factors Registries National Cancer Institute (U.S.)Odds Ratio Case-Control Studies Genetic Testing Treatment Outcome Multivariate Analysis Limit of Detection Kaplan-Meier Estimate Incidence Questionnaires Clinical Trials as Topic Cohort Studies Logistic Models SEER Program Confidence Intervals Cluster Analysis American Cancer Society Pilot Projects Feasibility Studies Genetic Counseling Prevalence

Geographicals3

United States China Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Ovarian Neoplasms Early Detection of Cancer Mammography Uterine Cervical Neoplasms Mass Screening Medically Uninsured Breast Neoplasms Vaginal Smears United States Neoplasms, Glandular and Epithelial Early Diagnosis Tumor Markers, Biological Sensitivity and Specificity Biological Markers CA-125 Antigen Cell Line, Tumor Gene Expression Regulation, Neoplastic Prostatic Neoplasms Prognosis Cystadenocarcinoma, Serous Neoplasms Lung Neoplasms Genes, BRCA1 Neoplasm Invasiveness Carcinoma Mice, Nude Antineoplastic Agents Neoplasm Staging Neoplasm Proteins Neoplasm Metastasis Drug Resistance, Neoplasm Colonic Neoplasms Reproducibility of Results Stomach Neoplasms Gene Expression Profiling Reverse Transcriptase Polymerase Chain Reaction Polymerase Chain Reaction Survival Analysis Genetic Predisposition to Disease Disease Progression Pancreatic Neoplasms Risk Factors Prospective Studies Survival Rate Cisplatin Retrospective Studies Antineoplastic Combined Chemotherapy Protocols Predictive Value of Tests Follow-Up Studies Mutation Paclitaxel Xenograft Model Antitumor Assays Genes, BRCA2 RNA, Messenger Risk Assessment Risk Colorectal Neoplasms Neoplasm Recurrence, Local DNA Methylation Cancer Vaccines Carcinoma, Squamous Cell Oligonucleotide Array Sequence Analysis DNA, Neoplasm BRCA2 Protein Blotting, Western Adenocarcinoma, Clear Cell BRCA1 Protein Disease-Free Survival ROC Curve Adenocarcinoma, Mucinous Age Factors Time Factors Endometrial Neoplasms Carcinoma, Endometrioid Urinary Bladder Neoplasms Peritoneal Neoplasms Proteomics Immunohistochemistry Adenocarcinoma Registries Antigens, Neoplasm Neoplasm Transplantation Cell Proliferation Tumor Cells, Cultured Carcinoma, Non-Small-Cell Lung Prostate-Specific Antigen Genotype Germ-Line Mutation Epididymal Secretory Proteins Antineoplastic Agents, Phytogenic Enzyme-Linked Immunosorbent Assay National Cancer Institute (U.S.)Odds Ratio Receptor, erbB-2 Case-Control Studies Apoptosis RNA, Small Interfering Genetic Testing Combined Modality Therapy Receptors, Estrogen

No FAQ available that match "biomarkers early ovarian cancer early detection of cancer"